These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18537635)

  • 1. Pathophysiological mechanisms of stress-induced intestinal damage.
    Gareau MG; Silva MA; Perdue MH
    Curr Mol Med; 2008 Jun; 8(4):274-81. PubMed ID: 18537635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropharmacology of stress-induced mucosal inflammation: implications for inflammatory bowel disease and irritable bowel syndrome.
    Santos J; Alonso C; Vicario M; Ramos L; Lobo B; Malagelada JR
    Curr Mol Med; 2008 Jun; 8(4):258-73. PubMed ID: 18537634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal pathobiology and molecular signature of epithelial barrier dysfunction in the small intestine in irritable bowel syndrome.
    González-Castro AM; Martínez C; Salvo-Romero E; Fortea M; Pardo-Camacho C; Pérez-Berezo T; Alonso-Cotoner C; Santos J; Vicario M
    J Gastroenterol Hepatol; 2017 Jan; 32(1):53-63. PubMed ID: 27087165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic psychosocial stress induces reversible mitochondrial damage and corticotropin-releasing factor receptor type-1 upregulation in the rat intestine and IBS-like gut dysfunction.
    Vicario M; Alonso C; Guilarte M; Serra J; Martínez C; González-Castro AM; Lobo B; Antolín M; Andreu AL; García-Arumí E; Casellas M; Saperas E; Malagelada JR; Azpiroz F; Santos J
    Psychoneuroendocrinology; 2012 Jan; 37(1):65-77. PubMed ID: 21641728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights in the etiology and pathophysiology of irritable bowel syndrome: contribution of neonatal stress models.
    Barreau F; Ferrier L; Fioramonti J; Bueno L
    Pediatr Res; 2007 Sep; 62(3):240-5. PubMed ID: 17622962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early life stress in mice is a suitable model for Irritable Bowel Syndrome but does not predispose to colitis nor increase susceptibility to enteric infections.
    Riba A; Olier M; Lacroix-Lamandé S; Lencina C; Bacquié V; Harkat C; Van Langendonck N; Gillet M; Cartier C; Baron M; Sommer C; Mallet V; Zill M; Robert H; Laurent F; Ellero-Simatos S; Théodorou V; Ménard S
    Brain Behav Immun; 2018 Oct; 73():403-415. PubMed ID: 29860025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered colonic sensory and barrier functions by CRF: roles of TLR4 and IL-1.
    Nozu T; Miyagishi S; Nozu R; Takakusaki K; Okumura T
    J Endocrinol; 2018 Nov; 239(2):241-252. PubMed ID: 30139928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation.
    Fukudo S
    J Gastroenterol; 2007 Jan; 42 Suppl 17():48-51. PubMed ID: 17238026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models.
    Miquel S; Martín R; Lashermes A; Gillet M; Meleine M; Gelot A; Eschalier A; Ardid D; Bermúdez-Humarán LG; Sokol H; Thomas M; Theodorou V; Langella P; Carvalho FA
    Sci Rep; 2016 Jan; 6():19399. PubMed ID: 26775847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome.
    Barbara G; Zecchi L; Barbaro R; Cremon C; Bellacosa L; Marcellini M; De Giorgio R; Corinaldesi R; Stanghellini V
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S52-5. PubMed ID: 22955358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in brain G proteins and colonic sympathetic neural signaling in chronic-acute combined stress rat model of irritable bowel syndrome (IBS).
    Zou N; Lv H; Li J; Yang N; Xue H; Zhu J; Qian J
    Transl Res; 2008 Dec; 152(6):283-9. PubMed ID: 19059163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour.
    O'Malley D; Julio-Pieper M; Gibney SM; Dinan TG; Cryan JF
    Stress; 2010 Mar; 13(2):114-22. PubMed ID: 20214436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From psychology to physicality: how nerve growth factor transduces early life stress into gastrointestinal motility disorders later in life.
    Chow CFW; Che S; Qin HY; Kwan HY; Bian ZX; Wong HLX
    Cell Cycle; 2019 Aug; 18(16):1824-1829. PubMed ID: 31272268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C; Lobo B; Pigrau M; Ramos L; González-Castro AM; Alonso C; Guilarte M; Guilá M; de Torres I; Azpiroz F; Santos J; Vicario M
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A marketed fermented dairy product containing Bifidobacterium lactis CNCM I-2494 suppresses gut hypersensitivity and colonic barrier disruption induced by acute stress in rats.
    Agostini S; Goubern M; Tondereau V; Salvador-Cartier C; Bezirard V; Lévèque M; Keränen H; Theodorou V; Bourdu-Naturel S; Goupil-Feuillerat N; Legrain-Raspaud S; Eutamene H
    Neurogastroenterol Motil; 2012 Apr; 24(4):376-e172. PubMed ID: 22272920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overlap between irritable bowel syndrome and inflammatory bowel disease.
    Spiller RC
    Dig Dis; 2009; 27 Suppl 1():48-54. PubMed ID: 20203497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal separation as a model of brain-gut axis dysfunction.
    O'Mahony SM; Hyland NP; Dinan TG; Cryan JF
    Psychopharmacology (Berl); 2011 Mar; 214(1):71-88. PubMed ID: 20886335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The joint power of sex and stress to modulate brain-gut-microbiota axis and intestinal barrier homeostasis: implications for irritable bowel syndrome.
    Pigrau M; Rodiño-Janeiro BK; Casado-Bedmar M; Lobo B; Vicario M; Santos J; Alonso-Cotoner C
    Neurogastroenterol Motil; 2016 Apr; 28(4):463-86. PubMed ID: 26556786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutritional approach to restore impaired intestinal barrier function and growth after neonatal stress in rats.
    García-Ródenas CL; Bergonzelli GE; Nutten S; Schumann A; Cherbut C; Turini M; Ornstein K; Rochat F; Corthésy-Theulaz I
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43(1):16-24. PubMed ID: 16819372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.